EPW

Empower Clinics

Stock
Stock
ISIN: CA29246V2030
Ticker: EPW
CA29246V2030
EPW

Price

Price

CHART BY

Frequently asked questions

What is the Earnings Per Share (EPS) for Empower Clinics?

Empower Clinics's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -0.053. EPS indicates the company's profitability on a per-share basis.

What is Empower Clinics's revenue over the trailing twelve months?

Over the trailing twelve months, Empower Clinics reported a revenue of $6.02M.

What is the EBITDA for Empower Clinics?

Empower Clinics's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$5.98M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Empower Clinics?

Empower Clinics has a free cash flow of -$5.86M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

Financials

EPS (TTM) 
-0.053
Revenue (TTM) 
$6.02M
EBITDA (TTM) 
-$5.98M
Free Cashflow (TTM) 
-$5.86M

Information

Empower Clinics, Inc. is an integrated healthcare company. It provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and medical diagnostics laboratories. The company operates through the following business units: Health & Wellness and Diagnostics & Technology. The Health & Wellness business unit offers a healthcare model offering preventative, diagnostic, and treatment services that focuses on patient experience. The Diagnostics & Technology business unit operates through KAI Medical Laboratory offers testing services ranging from hematology to hormone testing, endocrinology, toxicology, and immunology through its hospitals, medical clinics and pharmacies. The company was founded on February 20, 1997 and is headquartered in Vancouver, Canada.

Industries
Medical/ Nursing Services
Sector
Health Care

Identifier

ISIN
CA29246V2030
Primary Ticker
EPW

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation